供应商: 郑州艾利蒙生物科技有限公司 数量: 不限 保质期: 2年 保存条件: 按照原厂要求保存
英国国家生物制品检定所(National Institute for Biological Standards and Control,NIBSC)是WHO的一个国际标准品供应ZX实验室,它的核心工作是制备、保存和分发WHO用于检测生物制品质量的标准品。NIBSC制备的流感毒株和检测抗原、抗血清标准品,保障了各厂家顺利的研究和生产。NIBSC 是目前世界上 WHO 国际标准和参考材料的主要制作人和分发人(提供 95% 以上的标准)。对疫苗、ZL中的大多数生物技术产品以及其它许多生物产品的有效使用都取决于 NIBSC 所提供的国际生物学标准的可用性。
郑州艾利蒙生物科技有限公司代理挪威Chiron标准品,意大利Chromogenix肝素检测试剂,CP中检所标准品,EP欧洲药典标准品,BP英国药典标准品,USP美国药典标准品,JP日本药典标准品,LGC英国政府化学家实验室杂质标准品,TRC加拿大多伦多化学标准品,TLC药物标准品,MOLCAN药物标准品,NIBSC英国国家生物制品检定所标准试剂,美国Sigma-Aldrich公司试剂, 美国ChromaDex中草药标准品,瑞士CaroteNature类胡萝卜素标准品,法国Extrasynthese中草药标准品,WHO世界卫生组织药物标准品,NIST美国国家标准局标准品,IRRM欧洲标准局标准品等各种标准品,CIL美国剑桥同位素标准品,种类齐全,到货迅速。
联系人:任小姐
手机:18237190368
QQ: 1223408098
邮箱:sales@elements-bio.com
Product Number Description
00/410 MAPREC assay of poliovirus type 1 (Sabin). 480-A, 525-C DNA(1st International Reference Preparation)
00/416 Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
00/418 MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard)
00/422 High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
00/440 Influenza Antiserum A/Singapore/1/57 (H2)
00/442 Influenza anti B/Yamanashi/166/98 Serum (sheep)
00/464 Streptokinase (3rd International Standard 2001)
00/500 Botulinum Type A-E Antitoxin, Human Serum
00/530 Influenza Virus infectious B/Sichuan/379/99
00/542 Influenza anti- A/Chick/Scotland/59 (H5N1) Serum
00/544 Influenza Virus infectious B/Victoria/504/00
00/546 Influenza Antigen B/Johannesburg/5/99
00/552 Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3)
00/556 Influenza anti-B/Johannesburg/5/99/ Serum
00/562 Hepatitis A Virus for Nucleic Acid Amplification Techniques(2nd International Standard)
00/572 Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard)
00/574 Interferon Beta SER17 Mutein (Human, rDNA derived)
00/576 Interferon Beta (Human, Fibroblast-derived, Glycosylated)
00/614 Influenza virus infectious B/Guangdong/120/2000
007SP Human Anti-Pneumococcal capsule Reference Serum (1st International Standard)
01/412 Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody
01/420 Interleukin-17 (Human rDNA derived)(International Reference Reagent)
01/424 Vascular Endothelial Growth Factor, Human rDNA derived
01/426 Meningococcal group Y polysaccharide
01/428 Meningococcal serogroup W polysaccharide
01/450 Influenza anti B/Guangdong/120/2000 Serum
01/452 Influenza anti A/Panama/2007/99 (H3N2) HA serum
01/506 Botulinum type F antitoxin, equine
01/508 Botulinum type C antitoxin, equine
01/510 Botulinum Antitoxin Equine Type D
01/512 Botulinum type G antitoxin, equine
01/514 Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody
01/528 Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain] (Panel of 5 ampoules)
01/530 Oral Poliovaccine Sabin Type 2 reference strain (Panel of 5 ampoules)
01/532 Oral Poliovaccine Sabin Type 3 reference strain (Panel of 5 ampoules)
01/538 Anti-Meningococcal Serosubtype P1.16 mAb
01/546 Influenza Antigen B/Guangdong/120/2000
01/572 Anti-D Immunoglobulin(International Standard)
01/580 Thrombin, human(2nd International Standard)
01/600 Anti-Toxoplasma IgG, Human(International Standard)
01/602 Anti-Parvovirus B19, plasma, human(2nd International Standard)
01/612 Influenza Virus infectious B/Hawaii/10/01
01/614 Influenza Antigen A/New Caledonia/20/99
02/102 Influenza anti A/Panama/2007/99 Serum (sheep)
02/144 Anti-Meningococcal Serosubtype P1.15 mAb
02/148 Anti-Meningococcal Serosubtype P1.4 mAb
02/168 Prekallikrein Activator (PKA), Human(2nd International Standard)
02/176 Diphtheria Toxoid for use in Flocculation Test(2nd International Standard)
02/178 Anti-Meningococcal Serosubtype P1.2 mAb
02/180 Anti-Meningococcal Serotype P2.2a mAb
02/182 Anti-Japanese Encephalitis Virus Plasma, Human
02/184 Anti-Japanese Encephalitis (Anti-JE) Virus Control Plasma, Human
02/186 Anti-Dengue Virus Types 1+2+3+4, Human(Intrnational Reference Reagent)
02/206 Blood Coagulation Factor XIII, Plasma, Human (1st International Standard)
02/210 HIV (antibody), 1st International Reference Panel
02/226 IVIG negative control for use with IVIG + anti-D(International Reference Reagent)
02/228 IVIG + anti-D for use with negative control IVIG(International Reference Reagent)
02/230 Biotinylated Brad-5
02/232 Tetanus Toxoid Not Adsorbed
02/254 Insulin-like growth Factor I(1st International Standard)
02/262 Influenza Virus infectious B/Brisbane/32/2002
02/286 Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(International Reference Reagent)
02/294 Influenza Antiserum A/chick/Italy/1347/99 (H7N1)
02/306 Polio Virus Sabin Types 1, 2 and 3(2nd International Reference Reagent)
02/308 Anti-Meningococcal Serotype P3.4 mAb
02/310 Anti-Meningococcal Serotype P3.15 mAb
02/318 Botulinum Antitoxin Equine Type E
02/320 Anti-Meningococcal Serosubtype P1.3 mAb
02/336 Influenza Antigen A/New Caledonia/20/99
02/338 Influenza anti A/Panama/2007/99 Serum (sheep)
02/342 Protein C Plasma, Human(2nd International Standard)
03/104-014 HTLV-1 (antibody) Monitor Sample
03/110 Influenza anti B/Shangdong/9/97 Serum (sheep)
03/114 Anti-Meningococcal Serosubtype P1.1 mAb
03/116 Blood Coagulation Factor V, Plasma(1st International Standard)
03/124 Thrombopoietin, human rDNA derived
03/142 Anti-Meningococcal Serosubtype P1.14 mAb
03/148 Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st International Reference Reagent)
03/150 Keratinocyte Growth Factor (KGF,FGF-7)(1st International Reference Reagent)
03/152 Anti-HPA-1a (International Standard)
03/164 Anti-B minimum potency reference preparation(International Standard)
03/178 Vitamin B12, Serum Folate(International standard)
03/182 Anti-Meningococcal Serotype P3.21 mAb
03/188 Anti-A minimum potency reference preparation(International Standard)
03/190 Anti-HPA-3a(minimum potency)(International Reference Reagent)
03/192 Thyroid Stimulating Hormone, recombinant(1st International standard)
03/198 Influenza Virus infectious A/Kumamoto/102/02
03/200 Interleukin - 18 (Human rDNA derived)(International Referennce Reagent)
03/210 Anti-Meningiococcal Serosubtype P1.6 mAb
03/212 Influenza anti A/Wyoming/03/03 Serum
03/220 Influenza Antigen A/Wyoming/03/03
03/224 Anti-Meningococcal Serosubtype P1.10 mAb
03/226 Anti-Meningococcal Serosubtype P1.5 mAb
03/228 Protein S, Plasma, Human(2nd International Standard)
03/236 Anti-Meningococcal Serosubtype P1.13 mAb
03/242 Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum
03/244 Influenza anti A/chick/Germany/N/49 (H10N7) HA Serum (sheep)
03/258 Influenza Antigen A/New Caledonia/20/99 (IVR-116)
03/262 Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel)
04/102 Blood Coagulation Factor XI Plasma, Human(1st International Standard)
04/122 Anti-Meningococcal Serosubtype P1.12 mAb
04/132 IVIG + Anti-D for use with negative control IVIG
04/140 IVIG Negative Control for use with IVIG & Anti-D
04/150 Tetanus Toxoid For Flocculation Test(2nd International Standard)
04/160 Influenza Virus infectious NYMC X-147
04/166 TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st International Reference Reagent)
04/170 Influenza Virus infectious A/Wellington/1/2004
04/172 Influenza Virus infectious IVR-139
04/176 Plasmodium falciparum DNA for NAT Assays(1st International Standard)
04/198 Anti-Meningococcal Serotype P3.1 mAb
04/200 Parathyroid hormone 1-34 ,Recombinant, Human(International Standard)
04/202 Influenza Antigen B/ Jiangsu/10/2003
04/214 Influenza anti A/Vietnam/1194/04 (NIBRG-14) HA Serum (sheep SH440&SH442)
04/224 Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004
04/228 Influenza anti B/ Neuraminidase Serum
04/230 Influenza anti N1 Neuraminidase Serum
04/242 Influenza anti B/Jiangsu/10/2003 HA Serum (sheep)
04/246 Anti-Meningococcal Serogroup W-135 mAb
04/248 Anti-Meningococcal Serosubtype P1.19 mAb
04/252 Protein C Concentrate, Human(1st International Standard)
04/258 Influenza anti N2 Neuraminidase Serum(prepared from A/Wyoming/3/2003)
04/260 Influenza anti A/New Caledonia/20/99 HA Serum (sheep)
04/262 Influenza anti A/New York/55/2004 HA Serum (sheep)
04/264 Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157)
05/102 Influenza Virus infectious NYMC BX-7
05/106 Anti-HPA-1a minimum potency reagent(2nd International Reference reagent)
05/110 Influenza Virus infectious A/California/7/2004
05/112 Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).
05/122 Anti-syphilis plasma IgG (human)(1st International Standard)
05/130 Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)
05/132 Anti-syphilis plasma IgG and IgM (human)(1st International Standard)
05/134 Anti-human papillomavirus type 16 serum (1st International Standard)
05/138 Influenza Virus infectious B/Shanghai/361/2002
05/162 Alpha-1-Antitrypsin, plasma derived(1st International standard)
05/190 Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody
05/192 Anti Meningococcal Serotype P2.2b Monoclonal Antibody
05/232 Influenza Virus infectious A/Hiroshima/52/2005
05/234 Influenza Antigen A/Wisconsin/67/2005 - Like
05/236 Influenza anti A/Wisconsin/67/2005 Serum (sheep)
05/242 IVIG, Anti-D and Negative Control Panel
05/248 Anti Dengue, WHO Reference Panel
05/252 Influenza anti B Neuraminidase Serum (Sheep SH463)
06/102 Hepatitis C Virus for Nucleic Acid Amplification Techniques (4th WHO International Standard)
06/108 Influenza Virus infectious IVR-116
06/114 Influenza Virus Infectious A/PR/8/34
06/124 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard)
06/128 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard)
06/140 Pertussis Antiserum(human)1st IS-WHO international Standard.
06/142 Pertussis Antiserum (Human) 1st WHO Reference Reagent
06/164 Influenza Virus infectious 1 VR-142
06/166 Antithrombin Concentrate, Human (3rd International Standard)
06/170 Influenza Antigen A/New Caledonia/20/99
06/172 FEIBA Concentrate 1st NIBSC Working Reference Standard
06/192 Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466)
06/202 HPV Type 16 DNA (1st International Standard)
06/206 HPV Type 18 DNA (1st International Standard)
06/210 Medium Titre Meningococcal OMV Ref. serum
06/236 Influenza Virus infectious A/Solomon Islands/3/2006 07/132
06/242 Influenza Virus infectious NYMC-X161 B
06/B461-08 QCRHIV1QC5-Anti-HIV1: Quality Control Serum: Sample5
07/102 Influenza Antigen A/Solomon Islands/3/2006 (IVR-145)(H1N1)
07/104 Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum (sheep 467,468,469,470)
07/112 Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23
07/132 Influenza Virus infectious B/Malaysia/2506/2004
07/144 Influenza Virus infectious IVR-145,
07/146 Influenza anti A/HongKong/1073/99 like HA Serum (sheep)
07/148 Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum
07/150 Human Plasma Anti-Influenza H5N1 (1st International Standard)
07/162 Rabies vaccine (6th International Standard)
07/164 Anti-HBs immunoglobulin (2nd International Standard)
07/182 Blood Coagulation Factor IX Concentrate, Human, 4th International Standard”
07/184 Influenza anti B/Malaysia/2506/2004-HA Serum (sheep)
07/202 Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent)
07/214 Positive Control for use in flow cytometry cross matching (FCXM) and anti-HLA serology
07/216 Diphtheria Toxoid (Adsorbed) (4th International Standard)
07/222 RhD/SRY Plasma DNA sensitivity standard(1st International Reference Reagent)
07/226 Influenza Virus Infectious A/New Caledonia/20/99
07/228 Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard”
07/246 Influenza Virus Infectious IVR-147
07/268 Influenza Virus Infectious B/Brisbane/3/2007
07/270 BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent)
07/272 BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent)
07/274 BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent)
07/278 Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475)
07/286-012 Hepatitis B Surface Antigen Monitor Sample
07/288-011 Hepatitis B Surface Antigen 0.2IU/ml
07/290 Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6
07/294-005 Norovirus GII for Nucleic Acid Amplification Techniques
07/298-004 Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques
07/300-004 Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques
07/304 Anti-D for assuring operator and test performance
07/306 Anti-A and Anti-B in IVIG Positive Control( International Reference Reagent)
07/308 Anti-A and Anti-B in IVIG Negative Control (International Reference Reagent)
07/310 Anti-A and anti-B in IVIG: Limit reference preparation(International Reference Reagent)
07/316 Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.)
07/318 Meningococcal Group C Polysaccharide
07/326 Blood Coagulation Factors II, IX,and X Concentrate, 6th British Working Standard.
07/328 Unfractionated Heparin (6th I.S.)
07/336 Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60
07/338 Influenza anti A/Anhui/1/05 (H5)HA serum (IBCDC-RG6) (Sheep SH477)
07/348 Influenza Virus infectious NYMC X-171B
07/350 Blood Coagulation Factor VIII Concentrate (8th I.S.)
07/358 Influenza Virus infectious NIB-50
07/362 Influenza Virus infectious IVR-149
07/364 Chorionic Gonadotrophin, (5th International Standard)
07/B498-15 QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1
07/B498-16 QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1
08/100 Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1)
08/108 Influenza Virus Infectious NIBRG-91
08/114-004 Human Adenovirus serotype 2 for Nucleic Acid Amplification Techniques
08/118-004 Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques
08/120-004 Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques
08/126 Influenza anti A/turkey/Turkey/1/05(N1) NA Serum (NIBRG-74) (Sheep SH485)
08/138 Influenza Virus Infectious B/Florida/4/2006
08/140 Influenza Antigen B/Florida/4/2006
08/142 Influenza anti A/Anhui/1/05 (H5) HA serum (IBCDC-RG6) (sheep SH477)
08/148 Positive control for Luminex based anti-HLA Class II serology
08/150 HIV-2 RNA(1st International Standard)
08/154 Influenza Virus Infectious NIBRG-12
08/156 Influenza Virus Infectious NIBRG-23 30060 VE3
08/158 Fragile X Syndrome gDNA (1st International Genetic Reference Panel)
08/160 Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel)
08/174-006 Human Coxsackie B4 for Nucleic Acid Amplification Techniques
08/176-004 Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques
08/178-004 Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques
08/180-004 Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques
08/184 Influenza Antigen B/Malaysia/2506/2004
08/202 Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1)
08/204 Thyroid Stimulating Antibody (2nd I.S.)
08/208 Influenza Antigen Hong Kong/1073/99 (H9N2)
08/210 Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86)
08/214 Neisseria meningitidis serogroup C polysaccharide (1st International Standard)
08/216 Influenza Antigen A/Cambodia/R0405050/2007 (H5N1) NIBRG-88
08/218 Tetanus Toxoid Adsorbed (4th International Standard)
08/224-004 Human Herpes Simplex virus type 1 for Nucleic Acid Amplification Techniques
08/226-005 Human Herpes Simplex virus type 2 for Nucleic Acid Amplification Techniques
08/228 Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91
08/230 Streptodornase
08/246 Influenza anti A/Brisbane/10/2007- like HA serum
08/256 C1- Inhibitor, Concentrate (1st International Standard)
08/258 Antithrombin, Plasma (3rd International Standard)
08/262 C1 Inhibitor (Plasma)(1st International Standard)
08/266 Sex Hormone Binding Globulin.(2nd International Standard)
08/268 Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107
08/270 Anti-A and Anti-B in IVIG: Positive and Negative control panel(1st International Reference Reagent) (2 ampoules of 07/306 and 2 ampoules of 07/308)
08/278 Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C))
08/282 Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard)
08/298 Influenza Virus Infectious B/Brisbane/33/2008 30720 E5
08/300 Influenza Virus Infectious IVR-148
08/304 Influenza virus infectious NYMC X-175C
08/310-005 Varicella Zoster Virus(Type B) Working Reagent for Nucleic Acid Amplification Testing (NAT)
08/314-006 Human Cytomegalovirus for Nucleic Acid Amplification Techniques (AD169)
08/316-005 Epstein-Barr Virus for Nucleic Acid Amplification Techniques
08/318-005 Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing
08/320-004 Human Metapneumovirus Working Reagent for Nucleic Acid Amplification Testing
08/324-004 Human Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing
08/356 Influenza anti A/Japan/305/57 (H2) HA serum (A/Singapore/1/57-Like) (Sheep SH398)
08/362 Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109
08/B531-14 QCRVZVQC1-Anti VZV:Quality Control Serum: Sample 1
08/B534-07 QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3
09/100 Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503)
09/110 Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard)
09/112 Negative Control for use in flow cytometry cross matching (FCXM) and anti-HLA serology
09/130 Influenza Virus Infectious NIBRG-122
09/132-003 Human Coronavirus 229E Working Reagent for Nucleic Acid Amplification Testing
09/136 Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard)
09/138 Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.)
09/140 Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel)
09/148 Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505)
09/154 Clostridium Sordellii anti-serum(1st International standard)
09/162 Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard)
09/170 Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody
09/172 Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard)
09/174 Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A) (Cell Derived)
09/182 VWF Factor Concentrate (2nd International Standard)
09/184 Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14
09/186 Anti-Chagas Disease (TcII) Ig in Human Plasma(1st International Standard)
09/188 Anti-Chagas Disease (TcI) Ig in Human Plasma (1st International Standard)
09/196 Influenza Antigen A/California/7/2009 (H1N1v) (NIBRG-121xp) (Egg Derived)
09/234 Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-ß 3) (1st International Standard)
09/236 Influenza Virus Infectious IVR-153
09/242 Fibrinogen Concentrate (B)(2nd International Standard)
09/260 Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard)
09/264 Fibrinogen Plasma (D)(3rd International Standard)
09/266 Glial cell line-derived neurotrophic factor, GDNF
09/268 Influenza Virus Infectious NIBRG-121xp
09/272 Placental Growth Factor
09/274 Influenza Virus Infectious NYMC X-185
09/276 Influenza Virus Infectious A/Brisbane/59/2007
09/280 Influenza Virus Infectious NIB-64
09/284 Anti-Human Neutrophil Antibody 1a WHO Reference Reagent
09/296 Pro-Insulin, human (1st International Standard)
09/304 Influenza Virus Infectious IVR-155
09/306 Influenza Virus Infectious NIBRG-147
09/308 Influenza serology antigen reagent for haemagglutination inhibition assay Pandemic H1N1 2009 (X179A)
09/310 Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183)
09/316 Influenza Anti B Neuraminidase Serum (B/Florida/4/2006)
09/B577-06 QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample1
09/B584-10 QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1
09/B584-11 QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1
09/B588-05 QCRTOXOQC1-Anti-Toxoplasma Quality Control Serum: Sample 1
10/104 Reteplase
10/120 Influenza Antiserum A/Brisbane/59/2007 (H1N1)(IVR-148) HA (sheep 516 and 517)
10/128 Diphtheria Polyclonal Antibody
10/130 Diphtheria Monoclonal Antibody
10/132 Tetanus Polyclonal Antibody
10/134 Tetanus Monoclonal Antibody
10/136-001 HLA-DRB1 Genotyping Reference Panel
10/140 Anti-human papillomavirus[HPV] 18 (1st International Standard)
10/142 Negative control for Luminex based anti-HLA serology
10/150-006 Anti Hepatitis C Virus
10/152 HIV-1 RNA (3rd International standard)
10/154-004 Anti-HCV (1 in 8 dilution)(British Working Standard)
10/176 Interleukin-29 (Interferon Lamda 1)
10/178 Endotoxin (3rd International Standard)
10/188 Factor VIII Concentrate (13th British Standard).
10/198 Anti-malaria (Plasmodium falciparum) human serum(1st International Reference Reagent)
10/202 Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard)
10/214 Influenza Anti A/Hong Kong 1073/99 (N2)NA Serum(Sheep SH395 SH396)
10/218 Influenza Anti A/California/7/2009 (N1) NA Serum (Sheep SH 521)
10/226 Influenza Virus Infectious IVR-158
10/232 Genomic DNA for blood group genotyping RBC1(AR1R1)(International Reference Reagent)
10/234 Genomic DNA for blood group genotyping RBC12 (ODpsi)(International Reference Reagent)
10/236 Genomic DNA for blood group genotyping RBC4(OR1R2)(International Reference Reagent)
10/238 Genomic DNA for blood group genotyping RBC5(Brr)(International Reference Reagent)
10/242 Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard)
10/252 Factor VII Concentrate(2nd International Standard)
10/258 Influenza Antigen A/California/7/2009-like(NIB-74)
10/262 Diphtheria Antitoxin Human IgG(1st International Standard)
10/264 Hepatitis B Virus for Nucleic Acid Amplification Techniques (3rd WHO International Standard)
10/272 BCG vaccine of Moreau-RJ sub-strain(1st International Reference Reagent)
10/276 Influenza virus infectious BX-31
10/276 Influenza virus infectious BX-31
10/280 Anti-HLA Control
10/286 Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard)
10/B592-07 QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1
10/B594-05 QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1
10/B596-07 QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1
10/B596-08 QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1
10/B599-05 QCRCMVQC1- Anti CMV: Quality Control Serum: Sample 1
1050 Anti-Poliovirus monoclonal antibodies No: 1050 Type 2
11/106 Influenza Virus infectious A/Perth/16/2009
11/106 Influenza Virus infectious A/Perth/16/2009
11/108 Influenza Virus infectious NYMC X-187
11/108 Influenza Virus infectious NYMC X-187
11/126 Factors II and X Concentrate (4th International standard)
11/130 Influenza Virus Infectious NIBRG-14
11/130 Influenza Virus Infectious NIBRG-14
11/134 Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived)
11/170 Erythropoietin, recombinant, for Bioassay (3rd International Standard)
11/176 Low Molecular Weight Heparin 2 (3rd International Standard)
11/182-001 HBV DNA Working Reagent
11/184 High Molecular Weight Urokinase(2nd International Standard)
11/206 Influenza anti-A/Perth/16/2009 HA Serum
11/208-001 Parvovirus B19 DNA
11/210 Anti-human CD4 FITC conjugated 0.5ml
11/214 Blood Group Genotyping Reference Panel ((International Reference Reagent)
11/216 Chagas Antibody Reference Panel ( 1st International Standard)
11/218-001 MLH1/MSH2 Exon Copy Number Reference Panel
11/222 Influenza Virus Infectious NIB-79
11/226 Influenza Virus Infectious A/Victoria/361/2011
11/232 Influenza Virus Infectious B/Texas/6/2011
11/234 Immunoglobulin E(IgE) human serum (3rd International Standard)
11/236 Factor XIa (1st International Reference Reagent)
11/244 Influenza Virus Infectiious NYMC BX-49
11/B601-04 QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1
11/B603-05 QCRHIV2QC2-Anti HIV2:Quality Control Serum: Sample2
11/B604-001 QCRFLUAH5QC1 Influenza H5 PC1
11/B606-03 QCRNEGQC1-Negative Quality Control Serum: Sample1
11/B606-04 QCRNEGQC1-Negative Quality Control Serum: Sample1
11/B608-01 QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1
12/100 Influenza Virus Infectious NYMC X-217
12/104 Poliovirus Vaccine Inactivated (3rd International Standard)
12/106 Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39)
12/110 Influenza Antigen B/Wisconsin/1/2010 (cell derived)
12/112 Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187)
12/114 Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165)
12/116 Influenza anti-A/Victoria/361/2011-like HA serum
12/118 Influenza anti-B/Wisconsin/1/2010-like HA serum
12/122 Influenza virus infectious A/turkey/Italy/3889/1999
12/154 Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard)
12/168 Influenza Antigen A/California/7/09 (H1N1) (NYMCX-181) Egg derived
12/172 3rd HCV RNA Genotype Panel for Nucleic acid amplification techniques
12/174 Infectious Virus Influenza A/California/7/2009
12/176 Methylated Human Serum Albumin (mHSA)
12/188 Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived)
12/196-001 Hereditary Haemochromatosis Genotyping Reference Panel
12/198 Influenza virus infectious B/Wisconsin/1/2010 34490 E5
12/200 Influenza virus infectious B/Brisbane/60/2008 34500 E7
12/202 Influenza virus infectious NYMC BX-39
12/204 Influenza Virus infectious IVR-165
12/208 Parvovirus B19 (3rd International Standard)
12/224 HIV-1 NAT subtypes (Main)(2nd International Reference Preparation)
12/226 HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard)
12/248-001 JAK2 V617F Genotyping Sensitivity Panel
12/252 ADAMTS 13 Plasma (1st International Standard)
12/282 Diphtheria Toxin 1Lf/ml
12/284 Anti-meningococcal serogroup Y monoclonal antibody
12/288 Influenza Virus Infectious B/Massachusetts/2/2012
12/290 Influenza Virus Infectious B/Brisbane/36/2012
12/294 Influenza Virus Infectious NYMC BX-51C
12/298 Influenza Virus Infectious A/Texas/50/2012
12/302 Diphtheria Antitoxin Equine DI (International Standard)
12/306 Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard)
12/B611-01 Anti-VZV Quality control serum: Sample 1 QCRVZV IgM QC1
12/B612-02 QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1
12/B613-02 QCRRUBQC2-Anti-Rubella: Quality Control Serum: Sample 2
12/B614-04 QCRHBsQC1- Anti HBs Quality Control Serum: Sample 1
12/B620-03
本产品信息由(郑州艾利蒙生物科技有限公司)为您提供,内容包括(NIBSC标准品 特价优惠供应)的品牌、型号、技术参数、详细介绍等;如果您想了解更多关于(NIBSC标准品 特价优惠供应)的信息,请直接联系供应商,给供应商留言。若当前页面内容侵犯到您的权益,请及时告知我们,我们将马上修改或删除。
沪公网安备 31011502008050号